|
1
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nohata N, Abba MC and Gutkind JS:
Unraveling the oral cancer lncRNAome: Identification of novel
lncRNAs associated with malignant progression and HPV infection.
Oral Oncol. 59:58–66. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Flynn RA and Chang HY: Long noncoding RNAs
in cell-fate programming and reprogramming. Cell Stem Cell.
14:752–761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hammerman PS, Hayes DN and Grandis JR:
Therapeutic insights from genomic studies of head and neck squamous
cell carcinomas. Cancer Discov. 5:239–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cortez VS, Cervantes-Barragan L, Robinette
ML, Bando JK, Wang Y, Geiger TL, Gilfillan S, Fuchs A, Vivier E,
Sun JC, et al: Transforming growth factor-β signaling guides the
differentiation of innate lymphoid cells in salivary glands.
Immunity. 44:1127–1139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ni W, Song E, Gong M, Li Y, Yao J and An
R: Downregulation of lncRNA SDPR-AS is associated with poor
prognosis in renal cell carcinoma. Onco Targets Ther. 10:3039–3047.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao Y, Shi H, Ren F, Jia Y and Zhang R:
Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in
epithelial ovarian cancer. Exp Cell Res. 359:185–194. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi P, Zhou XY and Du X: Circulating long
non-coding RNAs in cancer: Current status and future perspectives.
Mol Cancer. 15:392016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fenner A: Prostate cancer: PCA3 as a grade
reclassification predictor. Nat Rev Urol. 14:3902017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sacco AG and Cohen EE: Current treatment
options for recurrent or metastatic head and neck squamous cell
carcinoma. J Clin Oncol. 33:3305–3313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao W, Liu JN, Liu Z, Wang X, Han ZG, Ji
T, Chen WT and Zou X: A three-lncRNA signature derived from the
Atlas of ncRNA in cancer (TANRIC) database predicts the survival of
patients with head and neck squamous cell carcinoma. Oral Oncol.
65:94–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kyzas PA, Loizou KT and Ioannidis JP:
Selective reporting biases in cancer prognostic factor studies. J
Natl Cancer Inst. 97:1043–1055. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dunne AA, Müller HH, Eisele DW, Kessel K,
Moll R and Werner JA: Meta-analysis of the prognostic significance
of perinodal spread in head and neck squamous cell carcinomas
(HNSCC) patients. Eur J Cancer. 42:1863–1868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu S, Wang P, You Z, Meng H, Mu G, Bai X,
Zhang G, Zhang J and Pang D: The long non-coding RNA EPB41L4A-AS2
inhibits tumor proliferation and is associated with favorable
prognoses in breast cancer and other solid tumors. Oncotarget.
7:20704–20717. 2016.PubMed/NCBI
|
|
17
|
Zou AE, Zheng H, Saad MA, Rahimy M, Ku J,
Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, et al: The
non-coding landscape of head and neck squamous cell carcinoma.
Oncotarget. 7:51211–51222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu JW, Kong Y and Sun X: Long noncoding
RNA NEAT1 is an unfavorable prognostic factor and regulates
migration and invasion in gastric cancer. J Cancer Res Clin Oncol.
142:1571–1579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Lena PG, Paz-Gallardo A, Paramio JM and
Garcia-Escudero R: Clusterization in head and neck squamous
carcinomas based on lncRNA expression: Molecular and clinical
correlates. Clin Epigenetics. 9:362017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Di Salvo TG: Evolving targeted therapies
for right ventricular failure. Expert Opin Biol Ther. 15:1263–1283.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji P, Diederichs S, Wang W, Boing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fanelli MF, Oliveira TB, Braun AC, Corassa
M, Abdallah EA, Nicolau UR, da Silva Alves V, Garcia D, Calsavara
VF, Kowalski LP and Chinen LTD: Evaluation of incidence,
significance, and prognostic role of circulating tumor microemboli
and transforming growth factor-β receptor I in head and neck
cancer. Head Neck. 39:2283–2292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang T, Huang W, Lu H, Zhang BY, Ma J,
Zhao D, Wang YJ, Yu DH and He X: Identification and validation a
TGF-β-associated long non-coding RNA of head and neck squamous cell
carcinoma by bioinformatics method. J Transl Med. 16:462018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du M, Huang T, Wu J, Gu JJ, Zhang N, Ding
K, Qian LX, Lu ZW, Zhang WJ, Tian XK, et al: Long non-coding RNA
n326322 promotes the proliferation and invasion in nasopharyngeal
carcinoma. Oncotarget. 9:1843–1851. 2017.PubMed/NCBI
|
|
27
|
Stahl D, Braun M, Gentles AJ, Lingohr P,
Walter A, Kristiansen G and Gütgemann I: Low BUB1 expression is an
adverse prognostic marker in gastric adenocarcinoma. Oncotarget.
8:76329–76339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Duan J, Qu Y, Deng T, Liu R,
Zhang L, Bai M, Li J, Ning T, Ge S, et al: Onco-miR-24 regulates
cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Protein Cell. 7:141–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu J, Frady LN, Bash RE, Cohen SM,
Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, et al:
MerTK as a therapeutic target in glioblastoma. Neuro Oncol.
20:92–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
